Melanovus Oncology melanovus.com


Melanovus Oncology is developing therapeutics for the treatment of metastatic melanoma, which is classified by the FDA as an orphan disease, yet represents a $3B US market and $7.5B WW market. Our approach is novel, and our management team has 120+ years of experience operating under a capital efficient model. We are currently seeking investment to further the development of these target immunotherapies.

Melanovus Oncology is developing therapeutics for the treatment of metastatic melanoma, which is classified by the FDA as an orphan disease, yet represents a $3B US market and $7.5B WW market. Our approach is novel, and our management team has 120+ y...Show all

Company (Alive / Active)

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Melanovus Oncology $0M Jun 13, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Melanovus Oncology Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)